Ethical aspects of vulnerability in research

Agrawal M (2003) Voluntariness in clinical research at the end of life. J Pain Symptom Manage 25(4):25–32, 10.1016/S0885-3924(03)00057-5

Beauchamp TL, Childress JF (2001) Principles of biomedical ethics, 2nd edn. Oxford, New York

Callahan D (2000) The vulnerability of the human condition. In: Kemp P et al (eds) Bioethics and biolaw, vol II. Rhodos International Science and Art Publishers, Copenhagen

Hurst SA (2008) Vulnerability in research and health care; describing the elephant in the room? Bioethics 2(4):191–202, 10.1111/j.1467-8519.2008.00631.x

Kottow MH (2005) Vulnerability: what kind of principle is it? Med Health Care Philos 7(3):281–287, 10.1007/s11019-004-6857-6

Lenk C, Koch P, Zappel H, Wiesemann C (2011) Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics. Eur J Pediatr 168(12):1473–1478, 10.1007/s00431-009-0956-6

Maio G (2010) Forschung an Kindern ohne Individualnutzen: Ist sie ethisch zu rechtfertigen? In: Marckmann G, Niethammer D (eds) Ethische aspekte der pädiatrischen forschung. Deutscher Ärzteverlag, Köln, pp 51–57

Nickel PJ (2006) Vulnerable populations in research: the case of the seriously ill. Theory Med Bioethics 27:245–264, 10.1007/s11017-006-9000-2

Office of the United Nations High Commissioner for Human Rights (2012) Article 7 of the International covenant of 16th December 1966 on civil and political rights. www2.ohchr.org/english/law/ccpr.htm . (13th September 2012)

Ross LF, Nelson RM (2005) Pediatric research and the federal minimal risk standard. J Am Med Assoc (JAMA) 295(7):759, 10.1001/jama.295.7.759-a

Seelmann K (2002) Drittnützige Forschung an Einwilligungsunfähigen. In: Donatsch A, Forster M, Schwarzenegger C (eds) Festschrift für Stefan Techsel zum 65. Geburtstag, Zürich, pp 569–587

Spriggs M (2004) Canaries in the mines: children, risk, non-therapeutic research, and justice. J Med Ethics 30(2):176–181

Wendler D, Belsky L, Thompson KM, Ezekiel EJ (2005) Quantifying the federal minimal risk standard. Implications for pediatric research without a prospect of direct benefit. J Am Med Assoc (JAMA) 294(7):826–883, 10.1001/jama.294.7.826